Abstract:Protein kinase C (PKC) is a key regulatory enzyme involved in the transduction of extracellular growth signals to the cell nucleus. It occurs in several isoforms, the exact functional roles of which have not been established as yet. The tumor-promoting agent 12-O-tetradecanoyl-phorbol acetate (TPA) is the classic activator of PKC and modulates the activity of the activating protein-1 (AP-1) transcription factor complex via this pathway. AP-1, in turn, induces cell proliferation in many tissues. In the present study, the PKC isoenzyme expression pattern in JEG-3 choriocarcinoma cells was analyzed. The results were compared with those obtained in HEC-1B endometrium adenocarcinoma cells, which had previously been characterized in this respect. To gain insight into the possible functional consequences of different PKC expression patterns, cell proliferation rates and AP-1 activity in response to TPA in both cell lines was studied. Western blot analysis of the PKC isoenzyme expression pattern revealed that JEG-3 cells are deficient in the PKC α, δ, and ε isoforms. These isoenzymes are strongly expressed in HEC-1B cells, with the α and δ being constitutively active. As opposed to HEC-1B cells, JEG-3 cells did not show an enhanced proliferation rate in response to TPA. Furthermore, TPA-treated JEG-3 cells did not exhibit any change in cell shape and refractility as observed in HEC-1B cells. AP-1 activity, as determined by a transfected AP-1 luciferase reporter plasmid, was induced 10-fold by TPA in JEG-3 cells, yet only threefold in HEC-1B cells. It is concluded from these data that differential expression of a subset of PKCs, e.g., the α, δ, and ε isoforms, may serve as an indicator of the proliferative potential in response to growth factors and mitogens. Furthermore, our data indicate that the inducibility of AP-1 activity does not necessarily reflect the proliferative capacity of a given cell type in response to classical tumor promoters such as phorbol ester.

Role of Protein Kinase B in Tryptase- Induced Gene Expression

Tryptase activates PKB in inflammatory reaction in ECV304 cells.

Up Regulation of Interleukin-8 Expressions Induced by Mast Cell Tryptase Via Protease Activated Receptor-2 in Endothelial Cell Line.

Effect of Tryptase on the Expression of IL-6 and TNF-α in Microvascular Endothelial Cell

Effects of BTK Signalling in Pathogenic Microorganism Infections

Cloning of Human Preprotachykinin-I Promoter and the Role of Cyclic Adenosine 5 '-Monophosphate Response Elements in Its Expression by Il-1 and Stem Cell Factor

Tryptase promotes breast cancer angiogenesis through PAR-2 mediated endothelial progenitor cell activation.

Hepatic Ischemia/Reperfusion Injury involves functional tryptase/PAR-2 signaling in liver sinusoidal endothelial cell population

PKC Isoenzyme expression and cellular responses to phorbol ester in JEG-3 choriocarcinoma cells

Protein Kinase C-u Participates in NF-kB Activation Induced by CD3-CD28 Costimulation through Selective Activation of IkB Kinase b

Casein Kinase Iϵ Plays a Functional Role in the Transforming Growth Factor-β Signaling Pathway

Targeted Overexpression of Cyclic AMP-dependent Protein Kinase Subunit in Toxoplasma Gondii Promotes Replication and Virulence in Host Cells.

Tryptase Promotes Atherosclerotic Plaque Haemorrhage in ApoE-/- Mice

Antagonistic Effects of Protein Kinase C Α and Δ on Both Transformation and Phospholipase D Activity Mediated by the Epidermal Growth Factor Receptor

The P38 MAPK Pathway is Involved in the IL-2 Induction of TNF-β Gene Via the EBS Element

Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome

Possible role of duration of PKC-induced ERK activation in the effects of agonists and phorbol esters on DNA synthesis in Panc-1 cells

Effects of RNA Interference-Induced Tryptase Down-Regulation in P815 Cells on IL-6 and TNF-α Release of Endothelial Cells

Activation of Protein Kinase C Triggers Its Ubiquitination and Degradation

P21-Activated Kinase-1 Signaling Regulates Transcription of Tissue Factor and Tissue Factor Pathway Inhibitor.

CKAP4 participates in tryptase-induced phenotypic conversion in atrial fibroblasts through PAR2/p38/JNK pathway